Upregulation of p50 expression abolished the downregulated expression of NLRP3 inflammasome components in NSCLC cells stably overexpressing MIR503HG and treated with NETs (Figure 7D). This evidence concerns the gene NLRP3 and non-small cell lung carcinoma.